| Controls | Stage 1 | Stage 2 | p-value |
Age | 35 (31 - 44) | 39.5 (30 - 44) | 42 (35 - 44) | 0.001 |
Weight | 74 (51 - 90) | 51 (44 - 58) | 51.5 (46 - 61) | <0.001 |
BMI | 26 (21 - 30) | 18 (18 - 22) | 18 (17 - 20) | <0.001 |
Preterm menopause | 4/40 | 12/20 | 15/20 | <0.001 |
Talk use | 3/40 | 20/20 | 18/20 | <0.001 |
Subfertility | 2/40 | 14/20 | 17/20 | <0.001 |
Fertility treatment | 2/40 | 13/20 | 14/20 | <0.001 |
Ovarian or breast cancer | 5/40 | 17/20 | 16/20 | <0.001 |
Familial cancer | 0/40 | 3/20 | 4/20 | <0.007 |
CA-125 | 20.5 (15 - 34) | 70.5 (39 - 95) | 125.5 (99 - 148) | <0.001 |
Prealbumin | 21.2 (15.5 - 30.6) | 12.8 (6.9 - 16.0) | 9.9 (4 - 15.5) | <0.001 |
Calprotectin | 550 (100 - 2780) | 3320 (2580 - 7930) | 3825 (2350 - 5990) | <0.001 |
Abnormal prealbumin | 0/40 | 15/20 | 18/20 | <0.001 |
Abnormal calprotectin | 0/40 | 16/20 | 17/20 | <0.001 |